Docetaxel Directly Injected into Uro-Oncologic Xenografts
Evaluation of Submicron Particle Docetaxel Directly Injected into Uro-Oncologic Xenografts
Suspensions of submicron particle taxanes (Figure 1) allow for direct administration of high, sustained levels of chemotherapeutics at the site of disease. Intratumoral (IT) injections of submicron particles of pure docetaxel (NanoDoce) into clear cell renal carcinoma (786-O), transitional cell bladder carcinoma (UM-UC-3) and prostate carcinoma (PC-3) xenografts were evaluated.